Prof. Madhu BhaskaranResearch Group Leader
Transforming Collaborative Healthcare: Efficient Addressing of Emerging Lifestyle Challenges
"The 6 largest economies in SEA (Singapore, Malaysia, Indonesia, Thailand, Philippines and Vietnam) are facing unprecedented rise in healthcare cost. Industry experts predicted that the rise of healthcare cost will outpace both GDP and population growth, leading to an estimated total healthcare cost of more than USD 750 billion by 2025."
In Singapore, healthcare expenditure is expected to triple by 2030 (to SGD 44 billion) driven by ageing population and increase of NCD prevalence. The Singapore government has allocated SGD 10.2 billion for healthcare expenditure in Budget 2018 aiming to build new healthcare capacity to meet the rising demand and invest in new medical technologies to improve care quality. In the next 5 years, we are expected to see more general and community hospitals, polyclinics, nursing homes and elderly care centres across the island.
International experts believe that Healthcare Innovation is the key to create a more efficient and sustainable healthcare system for Asia. Healthcare providers need to make significant investments in processes and technologies for cost reduction and increase patient outcome to succeed in the increasingly competitive environment. While healthcare sector is undergoing a system restructure and transformation process, the recent 1.5 million healthcare data breach in Singapore has highlighted our weakness in digital health transformation. Cyber security is a critical “cancer cell” that healthcare professionals need to focus before we benefited from the healthcare technologies.
The Asia healthcare challenges present tremendous opportunities to develop a world-class efficient and sustainable healthcare system. How to capitalize on the innovation trend to create new opportunities?
Questex Asia’s Healthcare Innovation Summit Asia will bring together 250+ senior stakeholders from regulators, policy makers, healthcare institutions, practitioners and technology innovators and solutions providers to discuss Asia healthcare innovation trends, collaboration strategies, investments opportunities in digital health and brainstorm partnership ideas to achieve quality healthcare and healthcare sustainability goals.
Networking & Learning
Data is the fuel of the digital economy.
So industries, companies and institutions that are custodian to a vast repository of information is a prime target for hackers. In recent times, we see an increasing number of attacks on health care across the globe because of the value of patient records and the lack of robustness in its cybersecurity strategy.
Forcepoint will discuss the basic scenarios that are conducive for a cyber-attack. Forcepoint recognises that the healthcare industry is changing the way that it interacts with the patient to the way it prescribes healthcare treatment. In this dynamic environment, Forcepoint will briefly illustrate the criticality of a dynamic and adaptive cybersecurity solution that is contextualised for health care institutions and the ecosystem on its transformation journey to minimise cyber risk exposure.
Khoo Teck Puat Hospital
KK Women's & Children's Hospital
National University Health System, Singapore
Kwong Wai Shiu Hospital
Frost & Sullivan
Changi General Hospital
Malaysian Genomics Research Center, MGRC
IHH Healthcare Berhad
* Top 7 reasons why you should Sponsor *
1. Interact with Key Buyers, influencers and decisions makers from across the Asia Pacific Region
2. Generate quality leads at you network directly with your targeted audience through this curated event
3. Increase your business opportunities with ease in the Asia Pacific Region
4. Achieve business growth through the multitude of opportunities made available to you
5. Amplify your brand positioning to create Top-of-Mind-awareness among senior industry executives
6. Enjoy a wide reach as your company brand and solutions are amplified at this strategic platform
7. Succeed in engaging your targeted audience through an array of customizable sponsorship packages
Associate Professor Madhu Bhaskaran co-leads the Functional Materials and Microsystems Research Group at RMIT University. She has won several awards and fellowships for her research including competitive Australian Research Council Postdoctoral Fellowship (2010-2014) and Australian Research Council DECRA Fellowship (2016-2018). In 2017 she was recognised with the Eureka Prize for Outstanding Early Career Researcher and also named as Australia’s Most Innovative Engineers by Engineers Australia. In 2018, she has won the Batterham Medal and the APEC Aspire Prize. Her research interests include functional oxide thin films, wearable technologies and stretchable electronics.
Dr. Daniel Chia Hock Thye graduated from the University of Singapore with B. Eng. (Hons) and was awarded Commonwealth Scholarship to pursue post graduate studies in innovations, systems design and technologies in UK. He graduated with M. Sc. with Essery Memorial Prize; and Ph. D. in Engineering and published papers in International journals. After returning from U.K., he obtained Diploma in Business Administration (NUS) and Diploma in Investments with prize from the Institute of Banking & Finance.
Dr. Chia served at the Singapore Technologies, where he worked in management, production, system designs and innovations. He went on to serve in Sembawang Corporation Limited, where he served in Corporate Development and was the Group Chief Information Officer of Sembawang Corporation Limite and the General Manager of RDC Pte Ltd, overseeing IT and Operation; and set up and operated engineering companies including RDC Medical Waste Incineration Pte Ltd.
He did part time lecturing in the National University of Singapore and the University of Newcastle upon Tyne on Information Technology for Business Applications, Innovations & Technopreneurship. He was invited to participate in lecture in NTU M. Sc. Technopreneurship & Innovation Programme on Strategic Management for New Ventures and Technology Firms.
Dr. Chia is currently the Director, Transformation Office, Khoo Teck Puat Hospital and serves in the Audit Committee of the National Kidney Foundation. He is also serving as the Chairman of School Advisory Committee of Riverside Secondary School.
Dr. Chia filed 16 patents locally and internationally of which 6 are for healthcare. Dr. Chia won a Public Service Award PBM from the President of Singapore for Community Services.
Mr. Doshi is a healthcare expert with multiple years of commercial, technical and strategic management experience. He is a registered pharmacist with a strong academic background in the clinical trial industry.
He has extensive experience in structuring and managing risk sharing deals in various roles worth over 1 billion USD as well as in clinical research across the pharmaceutical and CRO industry, spanning US, Europe and Asia. He is a Key Opinion Leader to Korean Health Industry Development Institute and has previously held senior business development and management roles at IQVIA, EPS International and ICON. He holds a Master’s Degree in Pharmaceutical Sciences, BSc Pharmacy with research focus in oncology.
He has a strong scientific and managerial background with a clear understanding of local/global solutions. He has good strategic appreciation and vision and is able to build and implement sophisticated plans with a proven track record.
Tamsin, a Fellow of the Royal Society for Public Health and member of DesignSingapore Council’s expert ‘Innovation by Design’ panel, has 20+ years of international experience in delivering change & transformation programmes, integrating risk communications, change leadership, and social innovation practices.
A graduate of Imperial College of Science, Technology and Medicine she was the first jointly-funded post holder between the London Borough of Barnet Local Planning Authority and Barnet Health Authority, pioneering integrated care initiatives. Subsequently working for the British Government’s Department of Health, she managed the UK’s longest running public health campaign, the Heartbeat Award.
Tamsin currently heads the Smart Health Leadership Centre at the National University of Singapore’s Institute of Systems Science, where she teaches digital leadership and health service transformation programmes. Tamsin established the Centre to assist stakeholders across the broad health ecosystem to transform the future experience of health through data, technology and innovation.
Tamsin is a skilled risk communications professional and published author, with international experience in leading and delivering fully integrated strategic communications, innovation and transformation programmes with award winning results.
Prior to joining NUS, she spearheaded the strategic communications & partnering strategies for the 2012 Major UK Civil Engineering Project of the Year, the New Tyne Crossing, transformation public perceptions and the project’s reputation.
Dirk de Korne is the Deputy Director, Medical Innovation & Care Transformation at KK Women’s & Children’s Hospital (KKH). He also holds a position as Adjunct Assistant Professor at Duke-NUS Medical School, Singapore, and Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Netherlands.
In KKH, he is responsible for the hospitals’ overall innovation strategy and execution, including the alignment and facilitation of initiatives and projects pertaining to cross-departments, multi-disciplinary collaborations towards patient service integration with relevant stakeholders.
Over the last 15 years, Dirk has focused on diffusion of innovations, quality and safety improvement and organizational strategy. He has been involved in, e.g., tele-health, e-health, health technology, risk management, human factors & ergonomics, performance indicators & benchmarking, safety culture, patient experience, design thinking, efficiency improvement and internal and external auditing.
He holds a MSc in Health Policy & Management from Erasmus University Rotterdam and a PhD in Public Health from University of Amsterdam.
Dr Ian Mathews is an Emergency Medicine Physician with the National University Health System (NUHS) with clinical responsibilities at both National University Hospital and Alexandra Hospital. He is also the Assistant Group Chief Technology Officer for the hospital group, focusing on data in healthcare and artificial intelligence solutions for clinical problems, as well as its application to innovation, and enterprise.
Besides his clinical work, Dr. Ian teaches as an Assistant Professor at the National University of Singapore (NUS), where he combines classroom academic rigour with practical bedside training. He is also a Singapore-Stanford Biodesign Fellow with experience in patient-centric medical technology, from ideation and innovation through to implementation.
Dr. Ian also has an avid interest in global health and technology’s application to healthcare, particularly in emerging fields such as blockchain and artificial intelligence. Dr. Ian is the Chief Medical Officer to AEvice health, a respiratory health medical technology (medtech) startup, as well as a founding team member of PRIME Respi, a startup that focuses on chronic lung disease. He concurrently advises other medtech startups in different fields of healthcare ranging from digital health and blockchain to prenatal monitoring. He believes that technological solutions can provide access and help reduce inequity in global healthcare delivery.
Dr Ow Chee Chung is currently the CEO of Kwong Wai Shiu Hospital. The hospital has now completed the major redevelopment to transform it into a Community Healthcare Hub. The hospital has doubled both its inpatient and outpatient capacities. It is now moving towards building a Regional Community Healthcare System
A medical doctor by training, Dr Ow also has a Master in Business Administration (MBA, Surrey). He has held several leadership appointments in the public service, VWOs and the healthcare sector such as the restructured hospitals and health institutions. He has a personal interest in the development of community care services.
Dr Milind Sabnis is the Director of the Healthcare Practice at Frost & Sullivan, Asia Pacific and is based in Singapore.
Milind has over a decade of consulting experience engaging global clients in the US, the UK and Asia Pacific. He specializes in strategy consulting, M&As, and public-private partnerships. He has advised top pharmaceutical/biotech companies, hospital groups, and ministries on market entry strategies, product lifecycle management, and marketing strategies that have positively impacted these organizations. While with the World Health Organization, he developed and successfully implemented various strategies to stop Polio transmission in one of the 3 high risk regions in the world.
He has spoken at and chaired multiple industry conferences and has been quoted in multiple industry magazines and journals. He has also been interviewed by various media, including BBC’s Asian Business Report.
He holds a Masters in Business Administration from the University of Cambridge, United Kingdom, a Doctor of Medicine specialising in Preventive Medicine from the University of Mumbai and a Bachelor of Medicine and Bachelor of Surgery from the University of Mumbai.
Dr Eugene Shum is the Chief Community Development Officer at Changi General Hospital and Director, Community Partnership at SingHealth Office of Regional Health. He oversees health, social and community engagement and integration of healthcare services in the community. Dr Shum is a public health physician. He is Adjunct Associate Professor at the Saw Swee Hock School of Public Health, National University of Singapore.
Dr Shum led the development of the Neighbours for Active Living Programme, a health and social integration programme that supports residents with high care needs in the community. Dr Shum is the Principal Investigator for the Ministry of National Development Land and Liveability National Innovation Challenge Grant on Care Line, a 24/7 urgent assistant telecare service.
Dr Pawel Suwinski is a medical professional with extensive knowledge and experience in clinical genomics, bioinformatics, healthcare informatics and economics. He is currently working with Malaysian Genomics Resource Centre Berhad as a clinical geneticist and medical bioinformatician. Prior to MGRC, he was a Principal Consultant with the Frost & Sullivan Asia Pacific, leading Healthcare Practice Division that focused on monitoring and analysing healthcare and life sciences emerging trends, technologies and market behaviour. Previous professional engagements included:
Dr T Thirumoorthy graduated in 1972 from the University of Malaya (UM) as the Best All Round Graduating Student. After spending more than two years of his professional life in UK, he decided to come to Singapore, and his first job was Registrar in Dermatology and Venereology at the then-Middle Road Hospital. He was appointed Consultant dermatologist and venereologist in 1985 before finally leaving the National Skin Centre for private practice in 1990. Dr Thiru has been a member of the Academy of Medicine since 1981, and has served in the Chapter of Physicians as a committee member from 1987 to 1989. He has been a Fellow of the Royal College of Physicians London since 1989 and College of Physicians and Surgeons of Glasgow since 1990. He has been a member of the Ministry of Health National Medical Ethics Committee (NMEC) since 2005, and an elected member of the Singapore Medical Council (SMC) from 2005 to 2008. He has been a member of the Ethics Committee since 1988, and served on the SMA Council from 1997 to 1999, during which he chaired the Ethics Policy and Review Committee. He was the Organizing Chairman of the SMA Annual Ethics Convention from 1997 to 2002, and played a pivotal role in establishing the SMA Centre for Medical Ethics and Professionalism (SMA-CMEP) in 2000. He served as the Director of the Centre from 2000 to 2003, and continues to serve as a Board Member till today. In 2004, he was conferred the SMA Merit Award, for his outstanding leadership and contributions in the area of medical ethics and professionalism.
Dr. Michael David Winther is Senior Director for Target Discovery at Engine Biosciences, a biotech company headquartered in Singapore. He has extensive experience in both industry and academic research in the UK and Canada prior to moving to Singapore in 2014 to take on the challenge of managing the national pharmacogenomics programme, SAPhIRE. He also held the position of Associate Director at the Genome Institute of Singapore, where he was responsible for business development and management of intellectual property. Prior positions in life sciences industries include: Senior Director of Drug Discovery at Xenon Pharmaceuticals in Vancouver, President of QuantaNova Canada in Nova Scotia and Department Head at Welcome Research Laboratories in the UK. Dr Winther graduated from the University of California at Santa Barbara in Biochemistry and Molecular Biology, obtained a PhD from the University of Stirling, Scotland and postdoctoral training at the University of Essex. His work has spanned diverse areas including vaccine, biological products, lipids, anti-sense oligonucleotides and small molecule drug discovery.
Jean Leong has more than 23 years of experience across branding , marketing and franchising for various industries, including interior furnishings, fine jewellery, apparel and fast-moving consumer goods. Since 2010, she has been heading the marketing division at Goodrich Global. As a key member of the management team, she has successfully launched new marketing and digital initiatives for the Goodrich brand in North Asia Southeast Asia China, India and the Middle East, She sets goals, monitors work and evaluates results to ensure that departmental objectives and operating requirements are met. Over her 8 years tenure, Jean has been playing an integral role in offering design consultative advice in co-branding projects like Jewelfest, MediaCorp TV sets’ designs and leading fashion magazine fashion shoots. And she has worked with celebrities like London based Ashley Isham, Iconic Fashion show producer, Daniel Boey, MediaCorp artists, socialites and interior designers in designing their spaces. Finally, for the recent Goodrich Global acquisition, she fostered and managed internal and external stakeholders’ relations with Sangetsu, the major shareholder based in Japan, sharing best practices across business units and facilitating product knowledge and expertise transfers.
Forcepoint is transforming cybersecurity by focusing on what matters most: people’s behavior as they interact with critical data and systems. This human-centric approach to cybersecurity frees employees to innovate by understanding the normal rhythm of user behavior and the flow of data in and out of an organization. Forcepoint behavior-based solutions adapt to risk in real time and are delivered via a converged security platform to protect network users and cloud access, prevent confidential data from leaving the corporate network, and eliminate breaches caused by insiders. Based in Austin, Texas, Forcepoint protects the human point for thousands of enterprise and government customers in more than 150 countries.
Goodrich Global is in the business of supplying and distributing wallcoverings, fabrics, carpets and flooring materials (laminate, vinyl, engineered timber, outdoor decking, rubber tiles (Indoor and Outdoor) from the South East Asia, Asia, Hong Kong, China, India and the Middle East regions.
In the hospitality and healthcare sectors, our commercial grade product offerings are specified in hotels and healthcare facilities worldwide. With an extensive list of branches located across Asia, our team is equipped to fulfill the most challenging of industry’s requirements. Each completed project is a testimony to our uncompromising standards on quality, workmanship and cutting-edge designs.
Our sterling reputation for reliability and excellence makes Goodrich your choice supplier, distributor, fabricator and partner for all projects. With the largest service and installation team in the region, we work closely with design firms and have particular expertise in providing high performance interior furnishings. Our offerings are screened and evaluated for eco-friendliness, flammability, tear strength, abrasion resistance, wash ability and stain resistance.
High performance driven products have been specified for the following types of facilities: • Hospitality Industry • Health Care Facilities • Commercial and Retail Buildings • Educational Institutions • Places of Interest • Religious Buildings • Residential Projects Our product range is diverse and creative with an unlimited choice of colours, patterns and textures.
eG Innovations is a leading provider of unified monitoring solutions, helping businesses across the globe to transform IT service delivery into business advantage, a center for productivity, growth and profit. Providing 360-degree performance visibility – from users to servers to networks and storage, physical, virtualized and cloud – of their entire IT infrastructure allow IT architects to determine how to right-size and optimize their IT infrastructures for maximum ROI.
eG Enterprise includes Real Users and Business Transaction Monitoring to allow IT teams understand how user experience is affected by infrastructure and applications bottleneck and be more responsive across service level agreements with multiple vendors and changing demands.
With patented automatic root-cause diagnosis technology designed for dynamic, inter-dependent physical, virtual and cloud infrastructures, eG Enterprise Suite helps Cloud and Managed Service Providers to be successful in delivering the expected performance and service availability and move up the value chain with many value-added features.
Doctors today view patients’ pathologies through traditional 2-Dimensional imaging such as X-Ray, Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scans. All of these requires a high level of visualization in the understanding of complex pathologies. 3D renders on the other hand lack the spatial appreciation that a physical 3D model would be able to provide to surgical practitioners.
As such, 3D printed medical models empowers surgeons with the ability to analyse and practice complex procedures before going into the operating theatre. These help them in discovering new minimally invasive procedures, ultimately reducing overall surgical time, patient risk and recovery time.
3D printed medical models have also been proven as a key communication tool in medical education today. Where these models facilitates the practice of medical procedures and the understanding of anatomical structures and their relationship.
Understanding each of these applications above, Creatz3D Medical Service Bureau pride ourselves as a solution provider for our customers, working together with them in providing the perfect solution for their needs. Being a service bureau that is focused entirely on medical applications, our seamless end to end solution guarantees a hassle-free experience in the conversion of CT/MRI images into 3D printed medical models.
Additionally with 15 years of application knowhow in various additive manufacturing technologies and post processing techniques. We are able to fabricate 3D printed medical model for every surgical/ educational needs. Such as, using the multi-material capabilities of our PolyJet 3D Printer which is able to emulate a range of textures from rigid to clear and rubber-like materials, providing the all-important tactile feedback during surgical simulation.
BinaryHealthCare serves to “Bridge the eHealth Divide” (in both LAMIC and Developed Countries) by enabling sustainable innovation in patient-centered care through stakeholders empowerment to achieve context-effective adoption of Digital Health as an enabler.
BinaryHealthCare is the social enterprise arm of BNHC, a ‘purpose-driven’ consulting firm offering training, technical and market strategy, solutions and advisory services, specifically addressing the eHealth domains within (but not limited to) the ASEAN, North Asia and Middle East region.
The Personal Connected Health Alliance (PCHAlliance) aims to make health and wellness an effortless part of daily life. The PCHAlliance, a non-profit organization formed by HIMSS, believes that health is personal and extends beyond healthcare. The PCHAlliance mobilizes a coalition of stakeholders to realize the full potential of personal connected health. PCHAlliance members are a vibrant ecosystem of technology and life sciences industry icons and innovative, early stage companies along with governments, academic institutions, and associations from around the world.
To support its vision, the PCHAlliance convenes the global personal connected health community at the annual Connected Health Conference, the premier international event for the exchange of research, evidence, ideas, innovations and opportunities in personal connected health.
The PCHAlliance publishes and promotes the global adoption of the Continua Design Guidelines, an open framework for user-friendly, interoperable health data exchange in personal connected health. The Continua Design Guidelines are recognized by the International Telecommunication Union (ITU), an agency of the United Nations, as the international standard for safe, secure, and reliable exchange of data to and from personal health devices.
The PCHAlliance accelerates technical, business, policy and social strategies necessary to advance personal connected health through its flagship key initiatives, including the Academy for Healthy Longevity, to promote lifelong health and wellness.
For more information, please contact: Francis Puno, Chairman – Southeast Asia at email@example.com
Healthcare Innovation focuses on how government, the pharmaceutical industry, and the healthcare service sector must work together to deliver innovative products and services for Asia’s rapidly changing economies and demographics. As one of the targeted verticals under Enterprise Innovation, the channel features specialized news and research on the healthcare industry, and a newsletter that is delivered to thousands of healthcare professionals across Asia.